Deals
Medical Firm Genesis MedTech Weighs Up to $500 Million HK IPO, Sources Say
- Device maker tapped Citic, Goldman Sachs, Morgan Stanley
- Singapore firm’s listing could come as early as next year
This article is for subscribers only.
Genesis MedTech Group, a medical device company, has selected advisers for a potential initial public offering in Hong Kong, according to people familiar with the matter.
The Singapore-based firm is working with Citic Securities Co., Goldman Sachs Group Inc. and Morgan Stanley on the proposed listing, which could take place as early as next year, the people said. Genesis could raise as much as $500 million in the IPO, though it could be significantly smaller depending on market conditions, one of the people said, asking not to be identified because the matter is private.